Mersana Therapeutics
IPOTargeted Therapies for Children and Adults
Cambridge, United States · $95.1M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- mersana.com
- Total Funding
- $95.1M
- Last Round
- $33.1M Series CMar 2015
- Rounds
- 3
About
Mersana Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates; acquired by Day One Biopharmaceuticals in 2025.
Summary
Mersana Therapeutics is a Biotech company based in Cambridge, United States. It has raised $95.1M in total across 3 rounds, most recently a $33.1M Series C round in Mar 2015. Investors include New Enterprise Associates, Rock Springs Capital and Fidelity Biosciences.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2017
Sign up to see all 5 rounds
Series C through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mersana-therapeutics"><img src="https://indexed.vc/api/badge/company/mersana-therapeutics" alt="Mersana Therapeutics on Indexed.vc" width="260" height="76" /></a>